A randomized evaluation of betrixaban, an oral factor Xa inhibitor, for prevention of thromboembolic events after total knee replacement (EXPERT) - Turpie, AG; Bauer, KA; Davidson, BL; EXPERT Study Group. (Thromb Haemost, 2009)